Kyra Chua

Study protocol for PREPARE: a phase II feasibility/safety randomised controlled trial on PeRiopErative Penicillin AlleRgy TEsting.

Joseph F De Luca, Fiona James, Sara Vogrin, Kyra Chua, Luke Fletcher, Justin Nazareth, Ranjan Guha, Andrew Hardidge, Ned Douglas, John Carruthers, Andrew Stewardson, Allen C Cheng, Douglas Johnson, Jo Douglass, Trisha Peel, Jason Trubiano

Journal article  |  2023  |  BMJ Open

INTRODUCTION: Patient-reported antibiotic allergy labels (AALs) are common. These labels have been demonstrated to have a negative..

In vivo and ex vivo have long-term durability in antibiotic-associated drug reaction with eosinophilia and systemic symptoms

Andrew Awad, Effie Mouhtouris, Fiona James, Kyra Chua, Natasha Holmes, Grace Gibney, Morgan Rose, Ana Maria Copaescu, Michelle Goh, Jason Trubiano

Journal article  |  2023  |  Journal of Allergy and Clinical Immunology

Inpatient Direct Oral Penicillin Challenge – A Large Prospective Cohort Study

Kyra Chua, Sara Vogrin, Jamie Waldron, Elise Mitri, Rebecca Hall, Ana Maria Copaescu, Natasha Holmes, Jason Trubiano

Journal article  |  2023  |  Journal of Allergy and Clinical Immunology

Phenotypic distribution and tolerability of re-vaccination in individuals with delayed hypersensitivity to COVID-19 vaccines

Joseph De Luca, Andrew Awad, Sara Vogrin, Jamie Waldron, Abby Douglas, Kyra Chua, Natasha Holmes, Jason Trubiano

Journal article  |  2023  |  Journal of Allergy and Clinical Immunology

A Shorter Time to DRESS – Redefining beta-lactam associated drug reaction with eosinophilia and systemic symptoms

Fiona James, Jamie Waldron, Sara Vogrin, Kyra Chua, Natasha Holmes, Joseph DeLuca, Michelle Goh, Abby Douglas, Jason Trubiano

Journal article  |  2023  |  Journal of Allergy and Clinical Immunology

Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial

James H McMahon, Jillian SY Lau, Anna Coldham, Janine Roney, Michelle Hagenauer, Sally Price, Mellissa Bryant, Jill Garlick, Anne Paterson, Sue J Lee, Jess O'Bryan, Anna Hearps, Gilda Tachedjian, Henry Pinskier, Cameron Phillips, Stuart Garrow, Nathan Pinskier, Robert Melvin, Luke Blakeway, Jessica A Wisniewski, et al.

Journal article  |  2022  |  ECLINICALMEDICINE

BACKGROUND: Well tolerated antivirals administered early in the course of COVID-19 infection when the viremia is highest could pre..

A Shorter Time to Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Redefining Beta-Lactam-Associated DRESS

Jamie L Waldron, Fiona James, Sara Vogrin, Kyra YL Chua, Natasha E Holmes, Joseph DeLuca, Michelle S Goh, Abby P Douglas, Jason A Trubiano

Journal article  |  2022  |  CLINICAL INFECTIOUS DISEASES

Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)

Fiona James, Michelle SY Goh, Effie Mouhtouris, Sara Vogrin, Kyra YL Chua, Natasha E Holmes, Andrew Awad, Ana-Maria Copaescu, Joseph F De Luca, Celia Zubrinich, Douglas Gin, Heather Cleland, Abby Douglas, Johannes S Kern, Constance H Katelaris, Francis Thien, Sara Barnes, James Yun, Winnie Tong, William B Smith, et al.

Journal article  |  2022  |  BMJ OPEN

INTRODUCTION: Severe cutaneous adverse reactions (SCAR) are a group of T cell-mediated hypersensitivities associated with signific..

Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol

Ana-Maria Copaescu, Fiona James, Sara Vogrin, Morgan Rose, Kyra Chua, Natasha E Holmes, Nicholas A Turner, Cosby Stone, Elizabeth Phillips, Jason Trubiano

Journal article  |  2022  |  BMJ OPEN

INTRODUCTION: Penicillin allergies are highly prevalent in the healthcare setting and associated with the prescription of second-l..

Penicillin Allergy Delabeling Program: an exploratory economic evaluation in the Australian context

Natasha K Brusco, Susan Bury, Kyra YL Chua, Sara Vogrin, Natasha E Holmes, Jason A Trubiano

Journal article  |  2022  |  INTERNAL MEDICINE JOURNAL

BACKGROUND: Internationally, clinical and economic advantages of low-risk penicillin delabelling have been explored, supporting ch..